Search results for "Prothrombin"

showing 10 items of 69 documents

Adverse Events in Treatment of Inherited Factor VII Deficiency: Final Analysis of the STER

2012

Abstract Abstract 2279 Introduction No evidence-based guidelines are available for the treatment of Factor VII deficiency. Replacement therapy (RT) is still influenced by different factors as rarity of the disorder, availability and supply of products and economic reasons. All RTs are not exempt of side effects and scanty data is available about the safety of the products currently used. Aim of this study was to analyze adverse events (AEs) of RTs for congenital Factor VII deficiency, as reported in Seven Treatment Evaluation Registry (STER). Design and Methods FVII deficiency patients treated for bleeding episodes, prophylaxis, and surgery were investigated for RT-related AEs over a period…

Pediatricsmedicine.medical_specialtySuperficial vein thrombosisFactor VIIbusiness.industryImmunologyAdverse Events Inherited Fasctor VII deficiencyCell BiologyHematologymedicine.diseaseBiochemistryThrombosisProthrombin complex concentratechemistry.chemical_compoundchemistryMedicineObservational studyFresh frozen plasmabusinessFactor VII deficiencyAdverse effectmedicine.drug
researchProduct

Permeabilit�ts�nderungen durch Dicumarol unabh�ngig von �nderungen der Prothrombinzeit

1950

Bei Mausen wurde nach Dicumarol per os in Dosen von 0,05–1 mg/g zirka 1–25 Std nach der Dicumarol-Gabe die Prothrombinzeit bestimmt und kurz danach die Odembildung der Hinterbeine bei der Durchstromung mit Tyrodelosung untersucht. In den meisten Fallen war innerhalb der ersten 7 Std die Prothrombinzeit unverandert, dagegen war eine erhohte Kapillarpermeabilitat eingetreten. Von 11 Std aufwarts war die Prothrombinzeit fast immer erhoht, wahrend die Gefaspermeabilitat in der Mehrzahl der Falle nicht mehr erhoht war. Nach akut nicht todlich wirkenden Gaben von 0,1–0,3 mg/g Dicumarol war die Permeabilitat nach Ablauf von 7 Std in der Mehrzahl der Falle sogar vermindert. Aus den Versuchen ist zu…

PharmacologyGynecologyProthrombin timemedicine.medical_specialtymedicine.diagnostic_testChemistryPharmacology toxicologymedicineGeneral MedicineNaunyn-Schmiedebergs Archiv f�r Experimentelle Pathologie und Pharmakologie
researchProduct

Evidence for Impaired Hepatic Vitamin K1 Metabolism in Patients Treated with N-Methyl-Thiotetrazole Cephalosporins

1984

SummaryIn 8 patients on no oral intake and with parenteral alimentation, administration of cephalosporins with N-methyl-thiotetrazole side chain (moxalactam, cefamandole), was associated with prolongation of prothrombin time, appearance in the circulation of descarboxy-prothrombin (counter immunoelectrophoresis and echis carinatus assay) and diminution of protein C. Acute administration of 10 mg vitamin Ki was followed by the transient appearance of vitamin K1 2,3-epoxide, indicating an impaired hepatocellular regeneration of vitamin K1 from the epoxide. Impaired hepatic vitamin K1 metabolism, tentatively ascribed to the N-methyl-thiotetrazole group, is one (but possibly not the only) cause…

Prothrombin timeDiminutionVitaminmedicine.medical_specialtymedicine.diagnostic_testmedicine.drug_classbusiness.industryCephalosporinHematologyMetabolismchemistry.chemical_compoundEndocrinologychemistryInternal medicinemedicineCefamandolebusinessProtein CMoxalactammedicine.drugThrombosis and Haemostasis
researchProduct

Manejo perioperatorio de los anticoagulantes orales directos en cirugía urgente y sangrado. Monitorización y tratamiento hemostático

2015

There is an almost unanimous consensus on the management of the direct new oral anticoagulants, dabigatran, rivaroxaban, and apixaban in elective surgery. However, this general consensus does not exist in relation with the direct new oral anticoagulants use in emergency surgery, especially in the bleeding patient. For this reason, a literature review was performed using the MEDLINE-PubMed. An analysis was made of the journal articles, reviews, systematic reviews, and practices guidelines published between 2000 and 2014 using the terms "monitoring" and "reversal". From this review, it was shown that the routine tests of blood coagulation, such as the prothrombin time and activated partial th…

Prothrombin timeRivaroxabanmedicine.diagnostic_testbusiness.industryPerioperativeCritical Care and Intensive Care MedicineDabigatranAnesthesiology and Pain MedicineCoagulationAnesthesiamedicineApixabanElective surgerybusinessmedicine.drugPartial thromboplastin timeRevista Española de Anestesiología y Reanimación
researchProduct

Clinical characteristics of COVID-19 patients in Latvia under low incidence in Spring 2020

2020

ABSTRACTBackgroundCOVID-19 is a new infectious disease with severe disease course and high mortality in some groups. Blood tests on admission to the hospital can be useful for stratification of patients and timely correction. Our study investigated the clinical features of COVID-19 patients in Latvia and differences in blood tests in groups with different disease severity.MethodsThe retrospective study included 100 patients hospitalized in Riga East Clinical University Hospital in Spring 2020. The severity of the disease course was classified by the presence of pneumonia and its combination with respiratory failure. We have assessed blood cells’ count, hemoglobin, hematocrit, erythrocyte se…

Prothrombin timemedicine.medical_specialtyCreatininemedicine.diagnostic_testTroponin Tbusiness.industryMortality rateRenal functionHematocritGastroenterologychemistry.chemical_compoundRespiratory failurechemistryInternal medicineErythrocyte sedimentation ratemedicinebusiness
researchProduct

The impact of whole blood processing and freezing conditions on the quality of therapeutic plasma prepared from whole blood

2014

Background The quality of whole blood (WB)-derived plasma preparations has been the subject of several studies, but there has been a lack of robust, comparative data for the different methods of processing and freezing. Study Design and Methods Six WB-derived plasma units were pooled and split (n = 16) and frozen within either 8 or 24 hours after WB collection, stored at 4°C or at room temperature (RT), and then frozen either slowly at −20°C or rapidly to below −30°C. Plasma units were tested for fibrinogen, Factor (F)V, FVII, FVIII, FXI, and von Willebrand factor (VWF), protein C (PC), protein S (PS) activity and free PS, prothrombin time, and partial thromboplastin time. Results FVIII was…

Prothrombin timemedicine.medical_specialtymedicine.diagnostic_testbiologyChemistryImmunologyHematologyPlasmaFibrinogenProtein SSurgeryAndrologyVon Willebrand factorhemic and lymphatic diseasesmedicinebiology.proteinImmunology and AllergyProtein CWhole bloodmedicine.drugPartial thromboplastin timeTransfusion
researchProduct

D-Dimer, Thrombin-Antithrombin III-Komplex (TAT) und Prothrombinfragment 1+2 (PTF)

1997

Two groups of 15 patients each with disseminated intravascular coagulation in association with septic disease were treated with low-molecular-weight heparin (lmw-heparin) in different dosages (group I: 1.5-5 IE/kg body weight (BW) per hour; group II: 8-15 IE/kg BW). We studied the levels of D-dimer, thrombin-antithrombin III complex (TAT), prothrombin fragments 1 and 2 (PTF), and global tests of coagulation like prothrombin time (PT), activated partial thromboplastin time (PTT), thrombin time (TT) and platelet count, plasminogen activation (PA) and fibrinogen concentration to estimate the success of heparin therapy in the two groups. TT and fibrinogen concentration were not suitable to foll…

Prothrombin timemedicine.medical_specialtymedicine.diagnostic_testmedicine.drug_classbusiness.industryPROTHROMBIN FRAGMENT 1.2Low molecular weight heparinGeneral MedicineHeparinThrombin timeFibrinogenAnesthesiology and Pain MedicineEndocrinologyInternal medicineD-dimermedicinebusinessmedicine.drugPartial thromboplastin timeDer Anaesthesist
researchProduct

Recomendaciones de uso de los anticoagulantes orales directos en el período perioperatorio

2012

Because of the characteristics of direct oral anticoagulants (DOA), the lack of an antidote to completely reverse their anticoagulant effects, the absence of standardization in monitoring of their effects, and limited experience of their use, specific recommendations for their management in the perioperative period or in emergencies are required. In elective surgery, in patients with normal renal function and low hemorrhagic/ thrombotic risk, DOA should be withdrawn 2 days before the intervention; when the hemorrhagic/ thrombotic risk is higher, bridge therapy with a low molecular weight hepatin beginning 5 days before the intervention is proposed as an alternative. In emergency surgery, sy…

Rivaroxabanmedicine.drug_classbusiness.industrymedicine.medical_treatmentAnticoagulantGeneral MedicinePerioperativemedicine.diseaseThrombosisProthrombin complex concentrateDabigatranAnesthesiamedicineElective surgeryAntidotebusinessmedicine.drugMedicina Clínica
researchProduct

Prolonged anaesthesia with isoflurane and halothane. Effects on hepatic function.

2007

Hepatic function was assessed pre-operatively and on the first and sixth postoperative days in 40 healthy patients who underwent prolonged maxillofacial surgery with isoflurane or halothane anaesthesia. No major changes were observed in hepatic enzymes or bilirubin. One-stage prothrombin time and Factor VII concentrations decreased on the first postoperative day and this change was more pronounced in the halothane group. The results support the use of isoflurane rather than halothane for prolonged anaesthesia in respect of the synthesising function of the liver.

Time FactorsBilirubinHepatic functionchemistry.chemical_compoundmedicineHumansProthrombin timebiologymedicine.diagnostic_testFactor VIIIsofluranebusiness.industryFactor VFactor VBilirubinFactor VIIAnesthesiology and Pain MedicinechemistryIsofluraneLiverAnesthesiabiology.proteinProthrombin TimeLiver functionHalothanebusinessAnesthesia InhalationHalothanemedicine.drugAnaesthesia
researchProduct

Possible coumarin-like mechanism of action for cephalosporins.

1984

In three patients treated with cephalosporins (one patient with latamoxef, two patients with cefazedone) vitamin K1 was injected to investigate whether this was followed by an increase in vitamin K1 2,3-epoxide plasma concentrations as compared to controls. Such a rise in K1-epoxide concentrations in the plasma can be demonstrated following treatment with coumarins. This reflects an inhibition of the vitamin K1-epoxide reductase in the liver. Coumarins are thought to induce hypoprothrombinaemia by such a mechanism. In all three patients we found a considerable increase in the vitamin K1-epoxide plasma concentrations following injection of 10 mg vitamin K1, whereas in normal subjects only tr…

VitaminMaleVitamin Kmedicine.drug_classCephalosporinReductasePharmacologychemistry.chemical_compoundCoumarinsDrug DiscoveryVitamin K deficiencyCefazedonemedicineHumansHypoprothrombinemiasGenetics (clinical)AgedClotting factorGeneral Medicinemedicine.diseaseLatamoxefCephalosporinsMechanism of actionchemistryBiochemistryMolecular MedicineFemalemedicine.symptommedicine.drugKlinische Wochenschrift
researchProduct